Nuvigil armodafinil regulatory update

CEPH received an approvable letter from FDA for an NDA of Nuvigil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSA/HS) and shift work sleep diso...